Dhampur Bio Organics Ltd

Dhampur Bio Organics Ltd has seen its investment rating upgraded from Sell to Hold as of 6 February 2026, reflecting a notable shift in technical indicators and a rebound in financial performance. The upgrade follows a comprehensive reassessment across four key parameters: quality, valuation, financial trend, and technicals, signalling a cautiously optimistic outlook for the sugar sector company amid mixed market conditions.

Dhampur Bio Organics Ltd, a key player in the sugar sector, has exhibited a notable shift in price momentum, transitioning from a sideways trend to a mildly bullish stance. Despite a stable closing price of ₹101.70 on 3 Feb 2026, technical indicators present a nuanced picture, reflecting both optimism and caution for investors navigating this micro-cap stock.

Dhampur Bio Organics Ltd has recently witnessed a significant technical development as its 50-day moving average (DMA) crossed above the 200-day moving average, forming a classic Golden Cross pattern. This event is widely regarded by market analysts as a bullish signal, indicating a potential trend reversal and a shift towards long-term upward momentum for the stock within the sugar sector.

Dhampur Bio Organics Ltd has seen its investment rating downgraded from Hold to Sell as of 1 February 2026, reflecting a complex interplay of technical, valuation, financial trend, and quality factors. Despite recent positive quarterly results, the company’s long-term fundamentals and technical indicators have raised concerns, prompting a reassessment of its outlook within the sugar sector.

Dhampur Bio Organics Ltd has experienced a notable shift in its technical momentum, transitioning from a mildly bullish stance to a sideways trend. Despite a recent downgrade in its Mojo Grade from Hold to Sell, the stock exhibits a complex interplay of technical signals that warrant close analysis for investors navigating the sugar sector.

Dhampur Bio Organics Ltd has reached a significant milestone by hitting a new 52-week high of Rs.115, marking a notable surge in its stock price amid a volatile trading session. This achievement underscores the stock’s strong momentum over recent days, supported by sustained gains and favourable technical indicators.

Dhampur Bio Organics Ltd has reached a significant milestone by hitting a new 52-week high of Rs.110.31, marking a notable surge in the stock’s performance amid a positive market backdrop.

Dhampur Bio Organics Ltd has seen a significant upgrade in its investment rating from Sell to Hold, driven by marked improvements across financial performance, valuation metrics, and technical indicators. The company’s recent quarterly results and market behaviour have prompted analysts to revise their outlook, reflecting a more optimistic stance on its near-term prospects within the sugar sector.

Dhampur Bio Organics Ltd has surged to a fresh 52-week high of Rs.108.84, marking a significant milestone in its stock performance amid a mixed market environment. The stock’s recent momentum reflects robust gains and a strong upward trajectory over the past few sessions.

Dhampur Bio Organics Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, signalling a change in price attractiveness that has caught the attention of investors amid a volatile sugar sector backdrop.

Dhampur Bio Organics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 January 2026, providing investors with the latest insights into the company’s performance and outlook.

Dhampur Bio Organics Ltd witnessed a remarkable surge on 23 Jan 2026, hitting its upper circuit limit of 20% to close at ₹95.76. This sharp rally was driven by intense buying interest, with the stock outperforming its sector and broader indices despite subdued market conditions.

Dhampur Bio Organics Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of bullish and bearish signals across key technical indicators. Despite a modest day gain of 0.19%, the stock’s broader technical picture remains nuanced, with mixed signals from MACD, RSI, Bollinger Bands, and moving averages suggesting cautious investor sentiment amid sectoral headwinds.

Dhampur Bio Organics Ltd has demonstrated a significant financial turnaround in the quarter ended December 2025, reversing a negative trend to post robust growth in profitability and operational efficiency. This shift comes amid a challenging sugar sector environment, with the company’s latest results signalling a potential inflection point for investors closely monitoring the industry’s cyclical dynamics.

Dhampur Bio Organics Ltd., a micro-cap sugar manufacturer with a market capitalisation of ₹547.23 crores, posted a net profit of ₹16.90 crores in Q3 FY26, a dramatic turnaround from the ₹15.99 crore loss recorded in Q2 FY26. However, this sequential recovery of 205.69% tells only half the story. On a year-on-year basis, the company's profitability collapsed by 346.36%, plunging from a ₹6.86 crore loss in Q3 FY25 to the current quarter's modest profit. The stock responded positively to the sequential improvement, trading at ₹82.43 following the results announcement, up 2.65% from the previous close.